NCT00596934: Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) |
|
|
| Completed | 2 | 9 | US | metreleptin, (originally A100, recombinant-human-Methionyl-leptin | Elif Oral, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan | Fatty Liver Disease, Nonalcoholic | 03/09 | 03/09 | | |
NCT01679197: Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy |
|
|
| Completed | 2 | 23 | US | Metreleptin, (originally A100, recombinant-human-methionyl-leptin | University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Fatty Liver Disease, Nonalcoholic, Nonalcoholic Steatohepatitis, Lipodystrophy | 07/16 | 07/16 | | |
